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Abstract 
 
Biomanufacturing has the potential to be one of the defining technologies in the 
upcoming century.  Research, development, and applications in the fields of 
biotechnology, bioengineering, biodetection, biomaterials, biocomputation and bioenergy 
will have dramatic impact on both the products we are able to create, and the ways in 
which we create them.  In this report, we examine current research trends in 
biotechnology, identify key areas where biomanufacturing will likely be a major 
contributing field, and report on recent developments and barriers to progress in key 
areas. 
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Executive Summary 
 
This white paper was requested by the Manufacturing Sciences & Technology Center of 
Sandia National Laboratories with the goal of educating the organization about 
developments in biomanufacturing technology and applications that would assist it in 
planning new programs.  Specifically we address the following tasks:  
 
• Examine current research trends in biotechnology 
• Identify key areas where biomanufacturing will likely be a major contributing 
field 
• Report on recent developments and barriers to progress in key areas, including 
fields that Sandia traditionally has not largely contributed to 
 
The ultimate goal of this report is to inform readers about emerging technologies and 
opportunities for Sandia to contribute to this emerging field of biomanufacturing. 
  
The starting point of this study was a general definition of biomanufacturing and an 
identification of the key contributing areas.  The most basic definition of 
biomanufacturing is the use of living organisms to manufacture a product.  
However, this definition is too general and broad to be of much practical use.  With this 
definition, biomanufacturing covers such well-established trades as wine, cheese and 
bread making, but it also excludes several potential key disciplines like biodetection and 
biomimetics.  Therefore we have 
revised this definition to encompass 
manufacturing methods that use a 
biological organism, or parts of a 
biological organism, in an unnatural 
manner to produce a product, as 
well as products designed to detect, 
modify, maintain and study 
biological organisms for use as new 
manufacturing agents.  This 
definition qualifies the use of 
biological organisms to processes that  
are unnatural, meaning that the 
organism being used has been 
modified on a molecular or genetic 
level to perform a function that it 
could not perform in its unaltered state.  This allows us to hold to the convention of 
exempting traditional manufacturing trades (bread making etc.) from being considered as 
biomanufacturing.  Even with a definition, biomanufacturing is not a field with strictly 
defined boundaries.  Rather, it may best be described by the disciplines it derives from 
and what fields contribute to it shown schematically in Figure 1.  The following fields 
could reasonably be considered key to the science of biomanufacturing:  
 
Biomanufacturing 
Bioengineering 
Biocomputation 
Biomaterials Bioenergy 
Biodetection 
Biotechnology 
Figure 1: Simple illustration of the connections between 
biomanufacturing and key contributing disciplines 
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• Biotechnology 
• Bioengineering 
• Biodetection 
• Biomaterials 
• Biocomputation 
• Bioenergy 
 
Biotechnology and bioengineering are both considered the parent disciplines of 
biomanufacturing while the remaining four fields are considered use areas. 
 
Any discoveries in the biotechnology or bioengineering fields will most likely trickle into 
areas of biomanufacturing.  Biotechnology research gives a complete picture of the 
fundamental processes involved in genetic expression.  Traditionally associated with the 
pharmaceutical industry, its applications are becoming more commercialized.  
Biotechnology includes such fields as Genomics, the study of the genetic material of life, 
and Proteomics, the study of proteins.  Most of the technologies used in modern Genomic 
studies are byproducts of the Human Genome Project and are fairly well established.  
Proteomics, on the other hand, remains in need of more advanced research.   
 
Bioengineering studies the mechanisms of biological processes and utilizes the 
knowledge of those mechanisms to modify organisms or to create new products.  
Although the definition of bioengineering sounds very similar to the definition of 
biomanufacturing, they differ in that bioengineering concentrates on modifying 
organisms for unnatural use and biomanufacturing is concerned with optimizing the 
application of unnatural organisms, as well as creating new technologies that improve the 
efficiency of creating unnatural organisms.  Research in this area generally falls into one 
of five categories:  
 
• Metabolic Engineering 
• Tissue Engineering 
• Cellular Engineering 
• Molecular Engineering 
• Nanoengineering (Nanotechnology) 
 
Metabolic engineering involves the direct modification of cellular metabolism through 
modification of protein production.  It is based upon the idea that optimal production 
within a cellular environment can be obtained through the modification of metabolic 
pathway.  The applications of metabolic engineering all revolve around the optimization 
of bioengineering.  The major barrier to progress in this field is the lack of basic research.  
The more that we understand about the way a cell controls its own manufacturing 
processes, the finer our control will be in tailoring those processes to our needs.   
 
Tissue engineering involves the controlled growth of living tissues and organs on three-
dimensional support structures, or scaffolds.  As with metabolic engineering, one of the 
major barriers to progress in this field is basic research.  Tissues tend to self-assemble 
and the methods by which they accomplish this are not well understood.  At this time, 
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tissue engineering is firmly in the realm of medicine and has applications in the creation 
of artificial organs, blood substitutes, neurological implants, and orthopedic devices.  
There are, however, opportunities to make this field more of a commercial venture.  One 
example is research into preventing the body’s rejection of implants.  An understanding 
of how tissues determine place and identify their own cells will assist in designing 
implants that do not initiate strong immune responses. 
 
Cellular engineering deals with directed modification of cell growth, differentiation, and 
division.  Cellular engineering also has strong ties to the pharmaceutical industry, and it 
is currently held back by a lack of basic research.  Any research into the process of cell 
growth will be useful in optimizing processes dependant on cellular reproduction.  
Processes that depend on cellular reproduction include DNA sequencing and many 
pharmaceutical production processes.  There are also applications in fields where 
optimized cellular processes would be extremely advantageous.  Examples would be in 
energy fields where optimized cellular replication could lead to improved biomass 
sources.   
 
Molecular engineering is the study of biomolecules and biomolecular processes to 
discover and create new high value biomolecules and to develop enabling technologies to 
produce them on a commercial scale.  This field has obvious ties to the pharmaceutical 
industry, but other applications will come in the form of optimized production of 
commercial products by biological means.  One often cited example is the production of 
ethanol.  However, microorganisms create much more complicated products every day.  
Basic research into the chemistry that a microorganism naturally uses affect the way in 
which industry synthesizes its chemicals.   
  
Nanoengineering (Nanotechnology) is probably one of the most talked about fields in 
research today.  Many of the manufacturing applications being studied in this field have 
corresponding processes in microorganisms.  As in molecular engineering, basic research 
into the processes by which cells create complex molecules will yield information that 
industry can use to optimize its own processes. 
  
Any research in biotechnology and bioengineering will have dramatic influences on 
biomanufacturing.  Both are rapidly developing fields that will give scientists the ability 
to create a whole new range of products that will improve the quality of human life.  The 
rest of the key disciplines are sciences that contribute to, and are affected by, 
biomanufacturing, and as such their major developmental barriers need to be adequately 
addressed.   
 
Biodetection is concerned with methods that identify and quantify biological organisms, 
their processes, and responses.  It relates to biomanufacturing in that any research or 
development in biodetection will contribute to the understanding and control of 
organisms used in biomanufacturing processes.  Biodetection also has a number of 
applications in national security.  Currently at Sandia there are several efforts underway 
to develop new biosensors specifically for use as bioweapon detectors.  But security is 
not the only field that would benefit from new biodetection technology.  Other fields that 
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would benefit include the medical, biotechnology, and bioengineering fields.  One major 
need in this field is for efficient manufacturing methods that would make currently 
developed biosensors commercially available.   
 
Biomaterials can be considered direct applications of biomanufacturing principles and 
products.  There are literally hundreds of potential applications for biomaterials, 
including adhesives, new synthetic materials, and new medical devices.  The major fields 
of research involved with biomaterials are biomimetics, biomineralization, and 
bioadhesion.  Biomimetics is the study and mimicry of advantageous surface properties 
or processes of living organisms for materials science and technology.  Biomineralization 
is concerned with how organisms form minerals.  Finally, bioadhesion is concerned with 
how biological organisms create membranes or substances that can be modified to 
promote or prevent adhesion to a given surface.  Nature has developed hundreds of ways 
to use surface, mineral, and structural properties, yet we understand only a few of them.  
The major barriers to advancement in these fields are a lack of basic research and failure 
to apply research that has already been conducted.   
 
Biocomputation is quite possibly the key field to all of the preceding fields.  
Bioinformatics is the largest biocomputation application.  It contributes to continuing 
research in biomanufacturing in that it creates a repository of reference material that will 
affect all other fields related to biomanufacturing.  One major barrier to progress is the 
need for faster computers and more efficient algorithms to handle the sheer volume of 
data being produced by all of the bio-related fields.  It also includes biomanufacturing 
processes relating to computers.  There are potential computing applications for 
biomolecules, DNA, and RNA, but most of the research in this field has not been 
considered for commercial production.   
 
Finally, bioenergy is an application of biomanufacturing research that is of great interest 
to the Department of Energy.  Bioenergy technologies have been explored for a number 
of years, but are not in commercial production because of their lack of efficiency when 
compared to current energy sources.  There is a definite need in this field for application 
and optimization of current technologies and processes. 
 
Biomanufacturing is an advanced manufacturing technology that involves the use of 
chemical, physical, and biological processes performed by living cells for use in other 
applications.  Biomanufacturing enables the manufacture of products with unique 
characteristics and has significant potential in the manufacture of several products such as 
polymers, energy sources, chemicals, food products, pharmaceuticals, and biodegradation 
(remediation) of hazardous materials. 
 
Perhaps the most unique and advantageous aspect of biomanufacturing is the excellent 
control that may be afforded during fabrication.  In particular, sequence-by-sequence 
building of polymeric materials may be possible.  Biological species can be used to 
synthesize polymers of more uniform chain lengths or chain branching than those 
produced by conventional synthesis techniques.  Additionally, biosynthesis could be used 
to produce specialty copolymers that are not available through traditional synthesis 
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methods.  These applications are of particular interest to SNL as we strive to understand 
polymers and nanoparticles in terms of their thermal, mechanical, optical, and electrical 
properties for use in nuclear weapons, satellites, and homeland defense applications. 
 
Other biomanufacturing areas of interest include fabrication of sensors and encryption 
tools.  It may be possible to utilize this technology to manufacture sensors that offer 
superior recognition of chemical and biological agents.  Currently, it is possible to 
manufacture sensors that are able to detect only one or a few agents.  However, 
development of the appropriate bioprocessing techniques will enable manufacture of 
sensors that are able to detect all materials of interest at once.  This is of tremendous 
interest in detecting and neutralizing potential terrorist attacks using these agents.  
Additionally, it may be possible to use biosequencing to provide encryption and 
subsequent decoding of complex, sensitive data.   
 
Biomanufacturing has the potential to be one of the defining technologies in the 
upcoming century.  Research, development, and applications in the fields of 
biotechnology, bioengineering, biodetection, biomaterials, biocomputation and bioenergy 
will have dramatic impact on both the products we are able to create, and the ways in 
which we create them.  Sandia National Laboratories has the expertise to contribute to 
any one of these fields.   
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 Biomanufacturing: An Introduction 
 
Biomanufacturing is both a very old and a very new science.  For centuries, man has been 
using biological organisms to produce desirable products such as wine, cheese and bread.  
These products all result from microorganism processes.  Only in the last decade have we 
been able to understand and directly manipulate these microorganisms to create desirable 
products they would not normally be able to produce.  Until recently, this type of 
manipulation has been considered a part of the biotechnology industry with close ties to 
pharmaceutical production.  Now the same techniques of biological manipulation and 
utilization are finding their way into other disciplines.  The expansion of these techniques 
has led to the emergence of biomanufacturing as a science that is both very similar and 
very different from its parent disciplines, biotechnology and bioengineering.  It also 
encompasses such varied fields as bioengineering, biodetection, biomaterials, 
biocomputation, and bioenergy.   
 
 
Statement of Task 
 
This white paper was requested by the Manufacturing Sciences and Technology Center of 
Sandia National Laboratories with the goal of educating the organization about 
developments in biomanufacturing technology and applications that would assist it in 
planning new programs.  Specifically, the following tasks were completed:  
 
• Examined trends in biotechnology, including research activities occurring in 
industry, universities and other national laboratories. 
• Identified key areas where biomanufacturing will likely be a major contributing 
field. 
• Reported on recent developments in key areas, including fields that Sandia 
traditionally has not largely contributed to, as well as any barriers to progress in 
those fields.  
 
All of the information provided in this report will serve the ultimate goal of informing 
readers about emerging technologies and opportunities for Sandia to contribute to this 
emerging field of biomanufacturing. 
 
Definition of Biomanufacturing 
The starting point of this study was a general definition of biomanufacturing and an 
identification of the key contributing areas.  As background research progressed it 
became increasingly apparent that biomanufacturing is not a field with strictly defined 
boundaries, but one that is best described by the fields that contribute to this science as 
shown in Figure 1.  In general, biomanufacturing is the use of living organisms to 
manufacture a product.  However, this definition is too broad to be of much practical 
use.  With this definition, biomanufacturing covers such well-established trades as wine, 
cheese and bread making, but it also excludes several potential key disciplines like 
biodetection and biomimetics.  Therefore we have revised this definition to encompass 
manufacturing methods that use a biological organism, or parts of a biological 
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Biomanufacturing 
Bioengineering
Biocomputation 
Biomaterials Bioenergy 
Biodetection 
Biotechnology 
Figure 1: Simple illustration of the connections between 
Biomanufacturing and key contributing disciplines 
organism, in an unnatural manner to produce a product, as well as products 
designed to detect, modify, maintain and study biological organisms for use as new 
manufacturing agents.  This definition qualifies the use of biological organisms to 
processes that are unnatural, meaning that the organism being used has been modified on 
a molecular or genetic level to perform a function that it normally would not in its natural 
state.  This allows us to hold to the convention of exempting traditional manufacturing 
trades (bread making etc.) from being considered as biomanufacturing.   
 
With this definition in hand, we can begin to define key fields that will contribute to the 
field of biomanufacturing.  We determined that the following fields could reasonably be 
considered key to the science of biomanufacturing:  
 
• Biotechnology 
• Bioengineering 
• Biodetection 
• Biomaterials 
• Biocomputation 
• Bioenergy 
 
Biotechnology and bioengineering are both considered the parent disciplines of 
biomanufacturing, and any research into or discoveries from these fields will most likely 
trickle into areas of biomanufacturing.  Biotechnology research gives a complete picture 
of the fundamental processes involved in genetic expression.  Bioengineering studies the 
mechanisms of biological processes and utilizes the knowledge of those mechanisms to 
modify organisms or to create new products.  Although the definition of bioengineering 
sounds very similar to the definition of biomanufacturing, they differ in that 
bioengineering concentrates on modifying organisms for unnatural use and 
biomanufacturing is concerned 
with optimizing the application of 
unnatural organisms, as well as 
creating new technologies that 
improve the efficiency of creating 
unnatural organisms.  
 
The rest of the key disciplines are 
sciences that contribute to, and are 
affected by, biomanufacturing.  
Biodetection is concerned with 
methods that identify and quantify 
biological organisms, their 
processes and responses.  It relates 
to biomanufacturing in that any 
research or development in 
biodetection will contribute to the 
understanding and control of organisms used in biomanufacturing processes.  
Biomaterials can be considered direct applications of biomanufacturing principles and 
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products.  Biocomputation contributes to ongoing research in biomanufacturing in that it 
creates a repository of reference material.  In addition, it is a product of  
biomanufacturing processes as they relate to computers.  Finally, bioenergy is an 
application of biomanufacturing research that explores the use of biological processes for 
energy production. 
 
 
Report Organization 
 
The goal of this report is to present relevant, unbiased information on the field of 
biomanufacturing and its contributing disciplines.  This paper has been divided by key 
disciplines.  Each section will define and discuss one of the above listed key disciplines.  
Each section will also include an example of current research, a list and brief explanation 
of key technologies in that field and a discussion of limitations to development in the 
field.   
 
Biotechnology 
 
Biotechnology is often seen as one of the parent disciplines to the many new and rapidly 
expanding bio-related disciplines.  While much has been accomplished in this field in the 
last decade, biotechnology is not a new discipline.  Man has been manipulating living 
organisms to improve his way of life and to solve problems for thousands of years.  The 
oldest discipline that could be considered biotechnology is the field of Agriculture, 
followed closely by a variety of fermentation and aging processes.  It was not until the 
late 1800’s that man began to take a more direct role in manipulating living organisms.  
The greatest progress began when Gregor Mendel established the first rules of genetic 
inheritance and when Von Leewenhoek became the first person in history to see a 
microorganism.  As the twentieth century dawned, new discoveries united the fields of 
industry and agriculture, while new fermentation methods allowed the industrial 
synthesis of common solvents and the first pharmaceuticals.  The term biotechnology was 
originally coined by a Hungarian engineer named Karl Ereky in 1919.  Ereky used the 
term to describe all lines of work by which products are produced from raw materials 
with the aid of living organisms.  As with biomanufacturing, biotechnology does not 
include traditional trades (bread making, etc.).  Throughout the twentieth century, 
biotechnology has continued to expand through intensive investigation of organisms for 
antibodies and vaccines as well as biological warfare.  Today, biotechnology has come 
to refer to the use of living organisms or their products to modify human health and 
the human environment.1  
 
The two sub-disciplines that have contributed the most to the field of biotechnology are 
the fields of Genomics and Proteomics. 
 
Genomics 
The history of genomics can be traced back to the 1960’s when scientists began to closely 
examine the structure of DNA.  The actual term “genomics” was not coined until 1986 by 
Thomas H. Roderick during a discussion about the name of a new planned journal.  The 
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Journal (Genomics) was to include articles that discussed gene sequencing data, gene 
mapping, new gene discovery, new genetic technologies, and genetic comparison of 
various species.  Today genomics is viewed as the methodical analysis of DNA, within 
the context of the entire genome, as well as a comparison of genes to one another 
without respect for the products that result when those genes are expressed.  The most 
famous study in Genomics is the Human Genome Project.  The Human Genome Project 
is a huge coordinated effort to map the human genome, identify all of its genes, and 
determine the entire nucleotide sequence.  This project includes work done in industry, 
universities, and national laboratories to meet the target date for completion of this 
project in 2005.  The Human Genome Project has done more to advance the technologies 
of gene sequencing, mapping, and database management than any other project in the 
history of mankind.   
 
One important point when discussing this field is the difference between Genetics and 
Genomics.  While both are concerned with an organism’s hereditary material (DNA) they 
concentrate on different aspects.  The study of Genetics first began in the 1850’s when 
Gregor Mendel published his work on genetic inheritance.  As such, Genetics is 
concerned with the relationship between the genetic material and its physical 
expression.  Genomics did not begin until the 1950’s when Watson and Crick published 
their paper on the structure of DNA.  Genomics is concerned with the structure of 
genes, DNA, and their relative positions and values when compared with one 
another.  Both fields focus on DNA as the hereditary material of a cell, but Genetics is 
concerned with how DNA is used and Genomics is interested in what DNA is.   
 
Technologies of Genomics 
Some of the most important technologies currently used in Genetics were advanced by 
the Human Genome Project, and include: DNA synthesis, Gene Amplification, DNA 
sequencing, DNA genotyping, Expression profiling, Imaging, and Microarrays.  We will 
briefly discuss each of these technologies with the exception of Microarrays, as they are 
better explained in the chapter on biodetection. 
 
The first step is to isolate the sequence of interest, which involves separating the 
fragment of interest from a host of other potential fragments.  For this, researchers use a 
Southern blot.  This involves separating the fragments by gel electrophoresis and then 
running it through a nitrocellulose filter paper.  Care is taken to make sure the fragments 
are deposited on the filter paper in the same positions they occupied on the gel.  The filter 
paper is then exposed to a solution full of radioactively-labeled probes, sequences 
designed to bind to a specific order of base pairs.  The filter is then dried, overlaid with 
X-ray film, and developed.  This gives the researcher a print of exactly which DNA 
fragments in the gel are of interest.   
  
DNA Synthesis 
DNA synthesis is a process carried out every day in every replicating cell on earth.  
Replicating cells have all of the necessary equipment to synthesize one copy of the entire 
piece of DNA, but the ability to replicate DNA is also necessary in order to map any 
genome or simply study the properties of DNA.  There are two procedures used to 
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produce the short piece of DNA (an oligonucleotide) needed for any given experiment: 
recombinant DNA cloning and automated DNA synthesis.   
 
Today most DNA sequences are synthesized by a DNA synthesizer, called a 
thermocycler, using a solid-phase synthesis technique.  Solid-phase synthesis involves 
attaching a primary residue, the 3' end of a nucleotide, to a substrate and then 
programming a sequence into a master control unit.  The synthesizer, a sophisticated 
fluid-handling device, then adds individual nucleotides in the desired order.  This method 
is different from the process ordinary cells use to replicate DNA in that nucleotides are 
attached to the 5' end of the newly-synthesized DNA instead of the standard 3' end.  
There are advantages and drawbacks to using this method.  One of the major advantages 
is the ease of use and specificity of this technique.  The major drawback lies in the fact 
that the sequence must be known before the DNA can be cloned.  This makes automated 
DNA synthesis useless when trying to clone novel DNA sequences.   
 
Recombinant DNA involves cutting and pasting existing DNA to form a novel DNA 
sequence.  Recombinant DNA cloning would then logically involve isolating a desired 
DNA sequence and inserting it into another larger piece of DNA.  The larger piece of 
DNA, called a cloning vector, is then placed in a desired microorganism, usually 
Escherichia coli (E.coli).  After the cloning vector is inserted, the bacteria are allowed to 
reproduce.  As the bacteria reproduce, the cloning vector containing the desired DNA 
segment is also reproduced.  These are the four general stages to recombinant DNA 
cloning: 
1. DNA Cleavage 
2. Synthesis of cloning vector 
3. Cloning 
4. Screening 
 
DNA cleavage involves the use of Restriction Endonucleases (RE) to cut the DNA 
strands into small fragments that have ‘sticky ends’.  RE’s are a type of enzyme that can 
cut completely through double-stranded DNA.  They are useful in that certain RE’s will 
cut between certain base pairs, allowing scientists to control exactly where the DNA is 
cut.  ‘Sticky ends’ are portions of unpaired bases at the ends of one strand of the double-
stranded DNA.  The nature of these ends is predictable based on the RE used to cut the 
DNA, and they will match up with the sticky ends of other fragments that have been cut 
using the same RE. 
 
The second step is the synthesis of a cloning vector.  The vector is chosen based on the 
size of the DNA to be cloned.  Usually a plasmid, a piece of circular DNA found in 
bacteria, is used as the vector, but plasmids are only suitable for small DNA pieces.  The 
two other options for cloning vectors are bacterial artificial chromosomes (BAC’s) or 
Yeast artificial chromosomes (YAC’s).  Once a suitable plasmid is selected, a section of 
it is removed using the same RE used to cut the desired piece of DNA.  Then using 
another enzyme, DNA ligase, the sticky end of the desired DNA is bound to the 
reciprocal sticky end of the cut plasmid.  Once the sticky ends have bonded, the 
recombinant DNA vector is ready for use.   
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The third step in this process is inserting the cloning vector into the desired 
microorganism.  There are three options available to the researcher: Transformation, the 
direct uptake of DNA from the cell’s environment; Conjugation, the direct transfer of 
DNA from one cell to another; or Transduction, the indirect transfer of DNA from one 
bacterial cell to another via a virus.  The most commonly used methods are 
transformation and transduction.  After the cloning vector is successfully inserted, the 
bacteria are allowed to replicate.   
 
Not every bacterium will successfully incorporate the vector, so there are several very 
clever ways to screen DNA clones for those that have successfully incorporated the 
vector.  One method involves including an additional antibiotic resistance gene on the 
cloning vector.  When the bacteria are grown in the presence of the antibiotic, only the 
clones with the resistance factor will survive.  The other option is to insert a gene on the 
cloning vector that will produce a specific enzyme that turns the bacteria containing the 
cloning vector blue.2,3  
 
Gene Amplification 
Gene amplification is carried out when large quantities of a DNA sequence are required 
for a given experiment.  Either one can purchase the desired number of oligonucleotides, 
or one can use a process called the Polymerase Chain Reaction (PCR) to quickly replicate 
more than enough oligonucleotides.  Karry Millis developed it in 1983 while acting as a 
staff chemist at Chetus Corporation.  In 1993, he won the Nobel Prize for chemistry.  
There are three steps to PCR shown schematically in Figure 2: 
1. Denaturation 
2. Annealing of Primers 
3. Primer Extension 
 
Denaturation is the breakdown of structure, in this case of DNA, from a double-helical 
structure to a single strand.  This process is accomplished by adding excess primer and 
heating the solution to 90o C.  The primers are short, complementary strands of DNA that 
bind to a specific section of the DNA to be copied.  The solution is then cooled from 
90°C to 60˚C to allow the primer to combine with the complementary single strands of 
DNA.  The primers finish as borders to the portion of the single strand to be amplified.  A 
solution of the four DNA nucleotides and very heat-stable enzymes, called DNA 
polymerases, are added to synthesize the complementary sequences that will fill the gaps 
on the single strand of DNA between the primers.  A complementary copy of the original 
single-stranded fragment is then produced and there will remain two copies of the 
original fragment.  These steps are repeated and after 20 cycles, more than 1 million (220) 
copies are produced, and will continue to be produced exponentially as the steps are 
repeated.  These steps can take some time when performed by hand which is why PCR, 
these days, is entirely an automated process.   
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DNA Sequencing 
One of the most important technologies in 
any sequencing operation is Gel 
Electrophoresis.  In this procedure, DNA 
pieces are added to a gelatinous solution 
and an electrical field is applied.  The 
DNA pieces separate according to size 
with the smaller pieces making it farther 
down the gel than the larger pieces.  The 
electric field hastens the separation 
process.  Gel electrophoresis is valuable 
because it can discriminate between DNA 
fragments that differ by a single base, 
known as nested fragments.4  
 
DNA sequencing is the process used to 
determine the exact order of base pairs in 
an oligonucleotide.  There are two types of 
sequencing available: Sanger sequencing 
and Maxam-Gilbert sequencing.   
 
Maxam-Gilbert sequencing uses brute-
force chemistry, while Sanger sequencing, also known as chain termination or dideoxy 
method, relies on enzymes to synthesize chains that vary in length by one base.  A 
desired piece of DNA is isolated and replicated thousands of times.  It is then divided into 
four test tubes.  Each test tube is given a set volume of one of the four types of 
dideoxynucleotides, ddATP, ddGTP, ddTTP, or ddCTP, one for each of the four nucleic 
acids, Adenine, Guanine, Thymine, or Cytosine, respectively.  Dideoxynucleotides differ 
from regular nucleotides in that they lack a functional group that would allow the next 
base in the sequence to be added.  When the dideoxy nucleotides are added to a solution 
along with the DNA polymerase, and an excess of the other three nucleotides, it 
guarantees that replication will terminate with the dideoxy nucleotide.  All four tubes are 
then separated using gel electrophoresis.  The end product is a gel column that, when 
developed, yields a grid showing DNA pieces separated by a number of nucleotides and 
the identity of the last nucleotide in the given DNA piece, usually designated with a 
radioactive marker.  Most modern DNA sequencing machines use this method, but they 
use fluorescent markers instead of radioactive markers.  That eliminates the need for a 
developing step and allows the computer to automate the process.5 
 
DNA genotyping 
Once a gene is sequenced, genotyping is necessary to determine where the sequence fits 
into the entire genome, and to mark it for genetic studies.  One of the most common 
genotyping methods lies in detecting single nucleotide polymorphisms (SNPs).  SNPs are 
common DNA sequence variations between individuals.  They occur at a high rate in the 
human genome (approximately one SNP per 1,000 base pairs).  To date, over 1.5 million 
Figure 2  PCR steps: 1) Denaturation of 
DNA (Black)  2) Binding of promoters (light 
gray)  3) Primer Extension (dark gray) 
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SNPs have been characterized, and can be used to advance our ability to understand and 
treat human disease.   
 
Genotyping technologies have proliferated rapidly in recent years.  Currently there are 
around one hundred methods available for detecting the genotypes of individual SNPs.  
The ideal SNP genotyping system would offer assay uniformity, high-throughput 
capacity, ease of assay design, and most importantly, accurate and reliable results.  
Currently, there is no one method that satisfies all of these requirements.  All of the 
current SNP detection techniques fall into three categories: 1) few SNPs, many samples, 
2) many SNPs, few samples, and 3) many SNPs, many samples.  Different techniques are 
more effective depending upon the application.  High-throughput analysis has only 
recently been optimized.  Even so, there is still no "gold standard" and different 
companies have devised their own technologies for genotyping.6 
 
One example of genotyping is a method developed in 2001 at Lawrence Berkeley Lab.  
Their process is a high-throughput haplotyping that can be used for a variety of medical 
applications.  Samples are scanned for haplotypes, SNPs that occur on each chromosome 
in a homologous pair.  The value of this new technique lies in the fact that it allows direct 
detection of all haplotypes present in the sample, without the need for statistical inference 
or the need for cloning PCR products.7 
 
Proteomics 
While DNA stores all of the blueprints for a cell, the proteins are the actual workhorses in 
a cell.  Serious study of proteins began with the Molecular Anatomy Program at Oak 
Ridge National Laboratories in the 1960’s.  Its goal was to produce a complete inventory 
of cells at the molecular level.  The intent was to discover and purify new pathogenic 
viruses, but the completion of the program would have impacts on many other medical 
fields.  In 1975, the program was moved to Argonne National Lab in response to new 
applicable technologies, including methods for large-scale vaccine purification, 
systematic fractionation of proteins, high-pressure liquid chromatography, high-speed 
computerized clinical analyzers, and 2D (two-dimensional) electrophoresis.  In 1980, 
interest in proteins was growing and an attempt was made to launch the Human Protein 
Index Project (HPI), but the proposal did not receive public backing.  The attempt was 
made again in 1983, but this time the HPI project was coupled with the Human Genome 
Project.  In 2001, a new wave of support for Proteomics arose, and currently there is a 
program called the Human Proteome project.  The first annual meeting for this program 
occurred in January 2003.8 Proteomics today is the study of proteins, but it also includes 
the identification, quantification, function, and location within the cell.  Current research 
in this field can be divided into three distinct subsets: protein profiling, protein-protein 
interaction, and structural biology.   
 
Just as in Genomics, the first step in any proteomic study is the ability to separate and 
identify the protein of interest.  The most popular technique is gel electrophoresis.  This 
process is the same as was discussed in the Genomics section in that the proteins must be 
denatured before they are separated.  This can pose additional problems when studying 
protein structure, as one must disrupt that structure to separate the protein.  There is also 
  19
another option when dealing with proteins.  One can separate 
them by standard electrophoresis or by Iso-electric focusing (IEF) 
which uses a pH gradient to separate them instead of an electric 
current.  There is also an additional technique, called 2D 
electrophoresis, that is used only with proteins.  This involves 
running two samples of protein on the same gel with each sample 
offset by 90° as shown schematically in Figure 3.  After 
separation, the protein of interest must be identified.  There are 
two options here: Northern blotting and Western blotting.  Both use the same process as 
Southern blotting (described in more detail in the Genomics section), but they isolate 
RNA and Proteins, respectively.  
   
Protein profiling concentrates on describing the origin and structure of a protein.  One 
major method of research in this field is the study of gene expression.  The basics of 
transcription (DNA to RNA) and translation (RNA to Proteins) are fairly well known.  
What is currently being done is a large-scale study of translation, by simply taking a 
piece of RNA and studying the protein produced.   
 
Protein-protein interaction is, as suggested by the term, the study of protein interactions.  
Protein interactions involve every aspect of a cell, from signal pathways, to the overall 
metabolism.  One method of studying these interactions is to monitor protein expression 
under varying circumstances.  This type of study is often performed for medical reasons.   
Structural biology concentrates on the relationship between the structure of a protein 
molecule and its function within a cell.  In an attempt to better understand this 
relationship, protein modeling has become a major contributor to this field.  With the 
completion of the Human Genome Project, protein research is in a prime position to be 
launched.  New advances in assay technology and mass spectrometry will contribute to 
the success of this project, but there is widespread opinion that new technology will be 
necessary if the project is ever to be completed.9  
 
 
Bioengineering 
 
The other parent discipline of biomanufacturing is bioengineering, the actual application 
of biotechnology.  It is often closely associated with biomedical engineering, but is 
slowly being commercialized beyond the medical field.  Bioengineering studies the 
mechanisms of biological processes and utilizes the knowledge of those mechanisms 
to modify organisms or to create new products.  Although the definition of 
bioengineering sounds very similar to the definition of biomanufacturing, they differ in 
that bioengineering concentrates on modifying organisms for unnatural use while 
biomanufacturing is concerned with optimizing the application of unnatural 
organisms, as well as creating new technologies, that improve the efficiency of 
creating unnatural organisms.  Research in this area generally falls into one of five 
categories:  
• Metabolic Engineering 
• Tissue Engineering 
Figure 3  2D Gel 
Electrophoresis 
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• Cellular Engineering 
• Molecular Engineering 
• Nanoengineering (Nanotechnology) 
• Biomedical Engineering 
 
Metabolic Engineering 
Metabolic Engineering involves the direct modification of cellular metabolism through 
modification of protein production.  It is based on the premise that optimal production 
within a cellular environment can be obtained through the modification of metabolic 
pathways.  Examples of such modifications include the alteration of the cells’ feedback 
systems to inhibit cellular production of a particular product or to eliminate those agents 
that consume the product.  The applications of metabolic engineering all revolve around 
the optimization of bioengineering.  The major barrier to progress in this field is the lack 
of basic research.  The more that we understand about the way a cell controls its own 
manufacturing processes, the finer our control will be in tailoring those processes to our 
needs.   
 
Applications include: 
• Production of metabolites and other products that are already made by the altered 
organism.  (e.g. the alteration of E.  coli to optimize the production of ethanol) 
• Production of new metabolites and other products not already made by the 
organism (e.g. the production of antibiotics) 
• Increasing the range of substrate utilization (e.g. production of ethanol by S.  
cerevisiae using starch) 
• Improvement or the design of new metabolic pathways for chemical degradation 
(e.g.  degradation of benzene by Pseudomonas putida) 
• Altering the cell properties that control bioprocessing (e.g. enhanced 
fermentation)   
 
Metabolic flux analysis is based on stoichiometric balances of metabolic species under 
the assumption of steady state.  This analysis is used to better achieve the applications 
listed above by presenting cell models that will aid in providing a more precise genetic 
modification of the microbes utilized.   
 
Amino acids are important targets in plant metabolic engineering because they provide 
chemical constituents essential to human and animal life.  In addition, they provide 
mechanical support to the plant.  Many of the genetic pathways that govern the 
production of amino acids in plants have been studied and can now be manipulated via 
metabolic engineering techniques to achieve desired properties. 
 
Another major developing area of research involves alteration of plant metabolic 
pathways to produce carbon molecules with useful functional properties.  To do this, 
scientists and engineers will need to obtain a better understanding of a plant’s 
metabolism, including the regulation of carbon flow.  As gene technology improves, 
better control of plants at the genetic level will be achieved.  This will make this 
technology much more feasible for practical, everyday usage.   
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It is understood that improved plant productivity will need to be achieved.  Chemical 
consistency studies will need to take place.  In addition, an improved understanding of 
the factors and theory of sustainable agriculture will provide a stronger foundation for 
this technology. 
 
Metabolic engineering presents to the scientific community new insights into bioprocess 
optimization through its goal to analyze, use, and control metabolic pathways.  This new 
paradigm utilizes a broad range of sciences including biochemistry, molecular biology, 
cell physiology, and biochemical engineering.  Bioinformatics and new discoveries in 
genomics and proteomics will also act to catalyze growth and development in this 
growing field in that it will allow researchers the capability to produce custom enzymes 
and metabolic pathways suitable to the desired task.   
 
Tissue Engineering 
Tissue Engineering involves the controlled growth of living tissues and organs on three-
dimensional support structures, or scaffolds.  As with metabolic engineering one of the 
major barriers to progress in this field is the lack of basic research.  Tissues tend to self-
assemble and the methods by which they accomplish this are not well understood.  At this 
time, tissue engineering is firmly in the realm of medicine and has applications in the 
creation of artificial organs, blood substitutes, neurological implants, and orthopedic 
devices.  There are, however opportunities to make this field more of a commercial 
venture.  One example is research into preventing the body’s rejection of implants.  An 
understanding of how tissues determine place and identify their own cells will assist in 
designing implants that do not initiate strong immune responses. 
 
Because of recent technological breakthroughs, the engineering of medical devices can be 
done using naturally occurring biological substances such as cells and biopolymers.  It 
has been common practice in medicine to treat organ and tissue failure by replacing the 
failed organ or tissue if it cannot be repaired through surgical reconstruction.  The 
problem with organ transplants is that donor organs are in short supply, their use may 
cause disease, and surgical replacement can require more than one procedure causing 
pain and loss of time.  Synthetic medical devices have been constructed, e.g. kidney 
dialyzers, to help to replace some of the function lost in tissue or organ failure.  These 
devices cannot compensate for the total loss of function.  Thus, tissue engineering applies 
principles from current technologies to develop biological substitutes for failed organs 
and tissue.   
 
One of the first real successes in tissue engineering was the development of artificial 
skin.  Scientists are now capable of providing skin grafts that will aid in healing wounds.  
Methods have been developed to minimize rejection of transplanted skin from a donor to 
a recipient.  One method involves the removal of the patient’s epidermis before 
transplantation.  This technique completely bypasses the need for immunosuppression.   
 
Other tissue engineering applications include: 
• Bioartificial Organs 
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• Blood Substitutes 
• Neurological Implants 
• Tissue Engineered Vascular Grafts 
• Orthopedic Devices 
 
One method of tissue engineering involves the use of cultured cells in contact with a 
supporting substrate.  The substrate may be entirely synthetic or synthetic with an extra 
cellular matrix of the normal adhesive proteins that are involved in the extra cellular 
environment of the cells.  Needless to say, the interaction of cells with the matrices is 
important to tissue engineering.  Cells become oriented in response to the underlying 
substrate.  This interaction is commonly referred to as contact guidance and is affected by 
the following physicochemical surface properties: 
• Surface Composition 
• Surface Charge 
• Surface Energy 
• Surface Oxidation 
• Curvature 
• Morphology 
 
Collagen is one popular example of the many extracellular matrix (ECM) 
macromolecules used as substrate for the attachment and growth of cells.  The ECM 
material can affect: 
• Cell Shape 
• Cytoskeleton 
• Cell Migration 
• Control of Cell Growth 
• Cell Differentiation 
 
The ECM interacts with the cytoskeleton of the cell and binds growth factors.  This 
interaction allows signals to cross the cell membrane.  Some of those signals may affect 
cell shape and protein synthesis.  Cells are attached to the ECM through cell surface 
proteoglycans, integrins, and cell attachment glycoproteins.  Attachment of cells to the 
ECM substratum is affected by the presence of specific macromolecules and interaction 
between ECM and the cell membrane.  The ECM is very important for the attachment 
and proper growth of cells.  Much work is still being done to understand the exact nature 
of the interactions between cells and the ECM and could provide information useful in 
the development of synthetic materials meant to mimic the ECM.   
 
Bioartificial organs can be a hybrid of synthetic materials and living cells.  Work has 
been done to produce an artificial pancreas (Sambanis), liver (Regenerex), nervous 
system (Bellamkonda), and many other organs.  One common limitation of organ 
engineering is the lack of techniques that would enable scaffolding in three dimensions.   
 
In bypass surgery, a saphenous vein or a mammary artery is implanted to bypass 
obstructed blood vessels near the heart.  The flow of blood causes a pressure on the 
vessel wall as well as a frictional shear force.  Much work is being done to tissue 
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engineer blood vessel substitutes for those people who do not have a usable vessel of 
their own for bypass surgery.   
 
Tissue engineering holds future benefits in medicine that can be used to provide superior 
medical treatment of troops deployed in combat situations and in that way, benefits the 
security of this nation.   
 
Cellular Engineering   
Cellular engineering includes directed modification of cell growth, cell differentiation 
and division, and cell-to-cell interactions and their physical properties.  Cellular 
engineering also has strong ties to the pharmaceutical industry, and it is currently limited 
by a lack of basic research.  Research into the process of cell growth will be useful in 
optimizing processes that are dependent on cellular reproduction.  Processes that depend 
on cellular reproduction include DNA sequencing and many pharmaceutical production 
processes.  There are also applications in fields where optimized cellular processes would 
be extremely advantageous.  Examples include improved biomass sources for energy and 
greater predictability of drug effectiveness in the pharmaceutical industry. 
  
Some of the important technologies involved in cellular engineering are standard tissue-
cultivation techniques, force measurement in cultivated cells, and measurements of cell 
adhesion.  Tissue-cultivation techniques involve taking a tissue sample, placing it on a 
suitable growth medium, and allowing the cell to grow and divide on its own.  The 
growth media must be carefully considered, as well as the cell type.  There are many cell 
types, especially fetal cells, whose differentiation we do not fully understand.   
  
Cell-adhesion measurements are extremely important to any study of cell dynamics.  
Many biological molecules and drugs affect cell adhesion, and thereby affect the 
organism.  Most adhesion assays are static, qualitative, or quasi-quantitative, but 
techniques used by Cellular Engineering Technologies, Inc., allow quantitative cell-
adhesion measurements.  They accomplish this by passing a current through the cell from 
a microscopic electrode and measuring the transcellular impedance.  There is also the 
matter of identifying the cell adhesion sites and the mechanisms by which biomolecules 
regulate cell-to-cell and cell-to-matrix adhesion.  The first issue that makes this 
identification complex is that the cytoskeleton of the cell is an integrated three-
dimensional network of filaments and adhesion proteins.  This physical framework 
allows mechanical forces to be passed to remote sites within the cell and even from one 
cell to another.  The second issue is that cell adhesion proteins are not uniform.  They 
respond differently to stimuli depending on where they are located in the cell.  Changes 
in cell adhesion can occur rapidly, so the measurements of cell-to-cell and cell-to-matrix 
adhesion need to be made separately but compared simultaneously.   
  
Cell force measurements are also an important part of studying cell dynamics.  As with 
cell adhesion, cell force is a primary target for both drugs and diseases.  Currently, the 
effects of drugs on cellular force are studied using animal models, but this process can be 
expensive, time-consuming, and imprecise.  One technique being used for laboratory 
study is to measure force in reconstituted artificial tissues consisting of cultured cells and 
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connective tissue to approximate a physiological model.  This technique is widely used in 
studies of muscular biology, wound healing, and pulmonary medicine.10 
 
Molecular Engineering 
Molecular Engineering is the study of biomolecules and biomolecular processes to 
discover and create new high-value biomolecules and to develop enabling technologies to 
produce them on a commercial scale.  This field has obvious ties to the pharmaceutical 
industry, but other applications will come in the form of optimized production of 
commercial products by biological means.  One often cited example is the production of 
ethanol, but microorganisms create much more complicated products every day.  Basic 
research into the chemistry a microorganism uses will affect the way industry synthesizes 
chemicals.   
 
Molecular engineering has been growing as a field since before the beginning of the 
Human Genome Project.  The characterization of biomolecules led to the development of 
the field of biochemistry, but it was the ability to synthesize those molecules that gave 
rise to the field of Molecular engineering.  Molecular engineering deals with 
biomolecules, molecules produced by biological organisms, and molecular processes to 
discover and create new high-value biomolecules at the molecular scale.  The goal is to 
develop enabling technology for the production of biomolecules to improve the quality of 
life and the environment.  Some of the enabling biological processes and scientific 
disciplines include directed genome evolution, metabolic-pathway engineering, protein 
engineering, analysis of functional genomics and proteomics, and high-throughput 
screening.  The development of the enabling bioprocess technologies for the production 
of high-value biomolecules of medical, agricultural, and economic importance is also a 
high priority.   
 
The design of novel biomolecules concentrates mostly on structure-stability and 
structure-activity relationships, which are based on the following five areas.  The 
interrelationships between these five areas are shown schematically in Figure 4. 
• Bioinformatics – includes functional genomics and proteomics.  
• Protein chemistry and protein 
engineering - deals primarily with 
protein structure-function and 
structure-activity relationships, 
structure-based design, and prediction 
of designed protein structure.   
• Recombinant techniques – includes 
random mutation, DNA shuffling, and 
phage-display techniques.  
• Metabolic-pathway engineering – 
includes the metabolic flux analysis.  
• Bioprocess engineering – used to 
develop enabling technology to 
produce the desired high-value 
biomolecules.   
Figure 4  Important components of biomolecular 
engineering and flow sheet for generation of 
novel biomolecules.1
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Bioinformatics include databases related to functional genomics and proteomics.  These 
databases provide the most current genetic sequence and function data, protein sequence 
and function data, and metabolic process data.  Use of bioinformatics databases has 
resulted in the design of many protein/peptide and metabolic molecules.  For more 
information on bioinformatics please refer to the segment of this paper with that title.   
 
Protein engineering, the application of proteomics, deals with both protein structure-
based design and prediction of a designed protein’s structure.  Both the function and the 
activity level of a protein are factors in protein structure.  Current research centers on 
characterizing and archiving protein structure, as well as characterizing and modeling 
protein structure-function and structure-activity relationships.   
 
Recombinant DNA techniques provide the capability of design, modification, and 
engineering of natural biomolecules.  Recombinant techniques include: 
• Oligonucleotide-directed Mutagenesis 
• DNA Shuffling 
• Phage-display Techniques 
 
Oligonucleotide-directed mutagenesis is the site-directed mutation of DNA with a 
designed oligonucleotide primer, with the intention of producing a specific novel protein.  
This method allows the researcher to design and modify a protein structure, but is limited 
by current knowledge of protein structure-function relationships and the approximate 
nature of current computer-graphic modeling technology.  Oligonucleotide-directed 
mutagenesis is also limited to the synthesis of one novel biomolecule at a time, a 
limitation that researchers have attempted to compensate for by creating expanded 
combinatorial libraries.  Using error-prone Polymerase Chain Reactions (PCR) to induce 
random point mutations as the DNA is 
replicated creates novel DNA 
combinations.  This method is limited 
by the enormous screening necessary 
to determine the results of the random 
point mutations.   
 
The DNA shuffling technique mimics 
the process of natural, sexual DNA 
recombination.  A group of related 
genes is randomly fragmented and 
subjected to denaturation and 
hybridization, followed by the 
extension of the potential fragment 
binding ends.  As the DNA is 
replicated with high fidelity, some of 
the fragments bind together, forming 
novel DNA combinations.  This 
process allows more direct 
 
Figure 5  The process for affinity selection of phage-
displayed peptides.11 
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recombination of all beneficial mutations from each completion of a PCR cycle, giving 
the researcher the ability to generate multi-step mutants with dramatically improved 
phenotypes. 
 
Phage-Displayed Peptide Library Screening was initially developed for isolation of a 
monoclonal antibody, an antibody that recognizes only one type of antigen.  The typical 
process for phage screening is shown in Figure 5.  This process begins with the target 
being immobilized on either a surface of beads or the wells of a microtiter plate (Step 1).  
A variety of possible matches to the target are placed in the solution and allowed to 
incubate with the target.  This gives the phages time to bind to the target (Step 2).  The 
plate is then washed to remove any unbound phages (Step 3).   The bound phages are 
eluted when the target is denatured, the process of partial or total alteration of the native 
structure of a macromolecule resulting from the loss of tertiary or tertiary and secondary 
structure that is a consequence of the disruption of stabilizing weak bonds.  The phages 
are then freed into solution (Step 4).  The eluted phages are then put through an 
amplification process, usually a PCR-type process (Step 5).  The amplified phage can 
then be re-used in the process until only the phages that most closely match the target 
remain.11 
 
Metabolic-pathway engineering is a new approach to understanding and using metabolic 
processes.  It is the targeted and purposeful alteration of metabolic pathways found in an 
organism in order to better understand and use cellular pathways for chemical 
transformation, energy transduction, and supramolecular assembly.  It typically involves 
the alteration of cellular activities by the manipulation of the enzymatic transport and 
regulatory functions of the cell through the use of recombinant DNA, metabolic-flux 
analysis, and other genetic techniques.  Metabolic-flux analysis is the detailed 
quantification of all metabolic fluxes in the central metabolism of a microorganism and is 
a combination of measured extracellular fluxes and measured intracellular labeling 
information.  It is used to determine targets for genetic manipulation and to determine the 
results a genetic manipulation will have on cellular metabolism.12  Metabolic engineering 
challenges include the need for methods to effectively express target proteins at desired 
levels, for improved tools to coax production of materials normally not produced or 
synthesized at extremely low levels, and for methods to provide insight into the complex 
interactions that exist between metabolic pathways.   
 
Bioprocess engineering includes both fundamental and applied research and development 
in the process engineering fields of bioreactors, biocatalysis measurements and control, 
and downstream processing.  It involves multidisciplinary approaches for integrative 
process design based on the hierarchical structure and decomposability of biosystems 
leading to analysis and synthesis.  New approaches for rational and evolving design of 
cellular systems are emphasized by taking into account the environment and constraints 
of technical production processes, integration of recombinant technology and process 
design, as well as new hybrid disciplines, such as bioinformatics and process systems 
engineering.   
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The molecular engineering paradigm involves the construction of beneficial materials and 
molecular agents at the micro-to-nano scale in a top-to-bottom fashion as opposed to 
nanoscale engineering that involves a bottom-up approach.  It draws from its contributing 
disciplines, i.e. genetic, protein, metabolic, and bioprocess engineering, what it needs to 
help accomplish this goal and proves to still be a very useful manufacturing 
methodology.   
 
Nanoengineering (Nanotechnology) 
Nanotechnology is probably one of the most talked-about fields in research today.  Many 
of the manufacturing applications currently under investigation have corresponding 
processes in microorganisms.  As in molecular engineering, basic research into the 
processes by which cells create complex molecules will yield information industry can 
use to optimize its own processes. 
 
According to the 1999 Interagency Working Group on Nanoscience, Engineering and 
Technology Report, nanotechnology is two things: 1) the creation of useful materials, 
devices, and systems through the control of matter on the nanometer scale, and 2) 
the exploitation of novel properties and phenomena developed at that scale.13  If 
properly developed, this technology will forever change the face of human existence, 
enabling us to manipulate atomic elements to create any desired material without the 
need of machining.   
 
Nanotechnology has the potential to take biomanufacturing to an entirely new scale.  
Efforts to enhance this technology have been hindered by the lack of international and 
even domestic cooperative efforts.  Increasingly, the U.S. government is stimulating 
academia, national labs, and the private sector to investigate this technology through 
massive funding and supporting National policy.  For example, the National Institute for 
Science and Technology (NIST) announced that it will support U.S. industry in “moving 
nanomanufacturing technologies into production within this decade by concurrently 
developing the scientific and engineering foundations necessary to support measurements 
and standards required to achieve effective and validated nanoscale product and process 
performance.”  Also, the National Science Foundation (NSF) released a request for 
proposals outlining its efforts to support nanotechnology for FY2003.  Attempts are being 
made at this time to encourage academic institutions to create courses on this subject to 
stimulate professional awareness and educate professionals to meet the growing demand 
for experts in this area.  
 
The idea of nanotechnology is not new.  The origin of this idea can be traced back to 
Richard Feynman's talk14 at the California Institute of Technology entitled “There’s 
plenty of room at the bottom”.  In his talk Feynman stated his belief that science would 
turn to the nanoscale, and outlined the need for better electron microscopes and 
supporting technologies for biologists and engineers who will eventually deal with 
systems at this scale.  Improvements in the use of scanning force microscopy to 
manipulate molecules individually and lithography for use in microelectronics and 
microelectromechanical systems (MEMS) are providing evidence that nanofabrication is 
feasible.   
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There are three primary areas of interest in nanotechnology: 
• Nanomeasurement 
• Nanomanipulation 
• Nanomanufacturing 
 
The third activity hints at the concept of “molecular manufacturing” using the first two 
technologies as the tools.  Many believe this may become feasible in the next 10-20 
years.  Molecular manufacturing could take place in nanoscale molecular-assembly 
factories, which will take basic chemical elements and produce a final product.  These 
factories may even have sensors or actuators that will respond to commands or 
environmental changes.  However, advancements in biotechnology, chemistry, 
computational tools, electrical engineering, and physics will need to take place in order to 
enable development of nanotechnology.     
 
The properties of electrons and atomic interactions within matter are influenced by 
material variations on the nanoscale.  It may be possible to control properties of materials 
by engineering them at the nanoscale.  Manipulation of the nanostructure of materials 
would allow scientists and engineers control over these properties without changing the 
actual chemical composition of the materials.  This manipulation may be done inside of a 
biological cell using the principles of self-assembly.  This bypasses the need to use 
miniature robots or devices, since the information necessary for assembly is already 
contained within the system.   
 
Biomedical Engineering  
One of the best-known branches of bioengineering is biomedical engineering (BME).  
Although the terms are often used synonymously, bioengineering is slowly moving away 
from being a strictly medical discipline.  BME involves “the acquisition of new 
knowledge and understanding of living systems through the innovative and substantive 
application of experimental and analytical techniques based on the engineering 
sciences.”15  It also involves “the development of new devices, algorithms, processes, and 
systems that advance biology and medicine and improve medical practice and health care 
delivery.”  BME includes not only the relevant applications of engineering to medicine 
but also to the basic life sciences.14 
 
Fueled by advances in the understanding of basic biological and cellular mechanisms that 
have great potential in benefiting public health and thus producing general improvements 
in the quality of life, bioengineering is on the upsurge.  Before leaving office, President 
Clinton signed a bill establishing the National Institute of Biomedical Imaging and 
Bioengineering, the newest member of National Institutes of Health (NIH).  This is a 
major contribution to the science in that it introduces a new element to the NIH structure, 
which tends to focus on distinct disease processes and organ systems.   
 
Increasingly, universities and other academic institutions are making enormous efforts to 
add bioengineering programs.  According to David Gough, professor and chair of the 
department of bioengineering, University of California San Diego, “A department of 
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bioengineering has been inaugurated at a major university nearly every month for the last 
several years.”  Contributing to this growth are improvements in public perception of 
bioengineering and the high-profile advances in genomic sciences.  Students are 
graduating in increased numbers thus producing a large community of engineers to meet 
industrial demand as this field continues to grow.   
 
 
Biodetection 
 
There are many motivating factors in the recent development of “biosensors” and other 
detection devices.  Historically, the motivation has been medical with the primary goal to 
use sensors to diagnose disease accurately and to avoid human error and misdiagnosis.  In 
more recent times, research has shifted to the detection of biological toxins that could be 
used in terrorist or military attacks on both military and civilian targets.  This report will 
distinguish between those sensors that have strictly medicinal applications and those that 
have tactical applications. 
 
All sensors have three major components: a receptor to receive information from the 
surrounding environment, a transducer to translate that information into a usable format, 
and a signal conditioner to analyze the information before it is output to a display.  
Biosensors are a specific type of sensor that use scientific principles to detect mechanical, 
chemical, and physiological events for medicinal purposes.  Additionally, they can use 
biodetection methods to identify biological agents.  Biodetection typically refers to the 
use of biomolecular recognition principles to “sense” biological agents.  Biomolecular 
recognition depends on the binding of ions, small-molecular-weight organics, and 
biological macromolecules to biological receptors.  Mechanisms for detecting and 
measuring the recognition event depend primarily upon the action of the biological 
receptor.  These receptors can be grouped functionally as biocatalytic (i.e. enzymes), 
bioaffinity (e.g. receptors, antibodies, and DNA), or microbial (e.g.  bacteria) in nature.  
When these bimolecular recognition elements are directly coupled to signal transducers 
(e.g. electrochemical, optical, or acoustic), they can generate an electrical signal 
proportional to the target analyte concentration and are typically referred to as 
biosensors.16 
 
The types of receptors and transducers will be discussed in this section:  
 
Receptors 
Bioaffinity 
Biocatalytic 
Microbial 
 
 
 
 
 
Transducers 
Electrochemical  
Piezoelectric  
Optical  
Thermal  
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Receptors 
Bioaffinity Receptors 
Bioaffinity sensors are a class of biosensors that use immobilized receptors to detect 
specific substances.  A schematic of a general biosensor is shown in Figure 6.   
 
There are four general types of biosensors: 
   
1.  DNA- and RNA-Based Probes that bind to strands of complementary nucleic acids 
from pathogens.   
 
2.  Antibody-Based Probes (“Immunosensors”) that use antibodies to recognize very 
specific antigens or sites on cellular components (epitopes).  Antibodies for a specific 
microbe need to be obtained in pure culture adding to production costs.  Antibodies must 
be screened for their binding characteristics such as affinity, and on and off rates.  It must 
also be known what epitope a specific antibody will recognize.   
 
3.  Antigen-Based Probes that are similar to antibody-based probes, but use antigens to 
detect antibodies.   
 
4.  Ligand-Based probes in which every cell has cell surface proteins that bind to other 
specific molecules and ligands that are specific to a particular microbial serotype or 
common to related groups. 
 
Biocatalytic Receptors 
Biocatalytic receptors expose specific substances, like a specific protein or toxin, to a 
catalyst that will break the substance into specific products.  Enzymes are the most 
popular biocatalysts because they are highly selective and efficient.  Depending on the 
enzyme, it can be very difficult or very simple to purify.  Enzymes can be used to break 
down polymers into their monomers, which can be detected, and can cause many other 
reactions to occur in which the products or reagents can be monitored. 
 
 
ligand 
(analyte) 
impurity 
receptor
biolayer
transducer surface
electronics 
Receptor Transducer 
Electronic signal
Output
Signal conditioner 
Figure 6 Schematic configuration of a biosensor 
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The most common enzyme that is used in biosensors is glucose oxidase.  Monitoring 
either the oxygen or hydrogen production performs glucose measurements.  This enzyme 
catalyzes the oxidation of glucose as shown schematically in Figure 7.   
 
 
 
 
 
 
 
 
 
 
 
 
 
(Glucose Oxidase) 
Glucose + O2 + H2O      →       gluconic acid + H2O2 
 
Figure 7  Oxidation of glucose via glucose oxidase catalyst 
 
Microbial Receptor 
Microbial biosensors consist of a transducer combined with immobilized viable or non-
viable microbial cells.  Non-viable cells are obtained from a process called 
permeabilisation in which the cell is exposed to an organic solvent that creates minute 
pores in the cell membrane.  This process allows the free diffusion of small-molecular-
weight substrates or products across the cell membrane, in addition to killing the cell.  
Another type of microbial biosensor involves engineering a cell that transports its 
intracellular enzymes into the periplasmic space.  In these cells the exported enzymes 
avoid membrane transport problems.  Non-viable cells or whole cells containing 
periplasmic enzymes can be used as an economical substitute for enzymes.  Viable cells 
make use of the respiratory and metabolic functions of the cell, where the analyte to be 
monitored is either a substrate or an inhibitor of the cell’s metabolic processes.   
 
An application of this technology is a genetically-engineered cell-based biosensor 
(GECBB) that can be used to classify biologically active agents.  Conventional 
immunoassays traditionally use some indicator (radiological, fluorescent, electrical, etc.) 
to measure the antigen or antibody concentration in a solution, while cell-based 
biosensors indicate a cell’s physiologic response to some bioactive stimuli.  This GECBB 
sensor combines the technologies of conventional immunoassays with that of cell-based 
biosensors.  Two cells, one naturally occurring and one genetically modified, are used as 
primary transducers and are placed on a sensor.  The genetically-modified cell is missing 
a specific membrane-bound receptor, while the natural cell has not been modified.  Both 
cells, by virtue of their location, are exposed to similar environmental conditions.  The 
combination of responses, either positive or negative, from both cells will tell the 
operator both the activity and the mode of entry of a particular unknown agent.  This 
setup has the potential to be run in parallel with many modified cells and one natural type 
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cell.  Limitations include the number of membrane-bound receptors that can be removed 
before the cell is inactivated and the number of unknowns that can be run simultaneously.   
 
Biological agents must be immobilized in order to interact with the transducer.  There are 
four methods of immobilization: 
• Adsorption 
• Direct cross-linking or Entrapment  
• Encapsulation or confining 
• Covalent Binding 
 
In adsorption, there is weak binding (i.e. hydrogen or charge-to-charge) most often to 
cellulose, collagen, or collodion, which may be reinforced with a cross-linking agent such 
as glutaraldehyde.   
 
In entrapment, the biological agent is entrapped in a gel by formation of a cross-linked 
network around the agent.   
 
Encapsulation and confining most often involve an enzyme system.  The agent is first 
enclosed within a semi-permeable spherical microcapsule or the agent is placed directly 
on the transducer where it is held in place by a semi-permeable membrane.   
 
Finally, covalent binding typically involves a substrate hybridized with hydroxyl (OH), 
amine (NH2), carboxyl (COOH), and Sulfahydryl (SH) groups.  The biological agent is 
then covalently bonded to one or more of the groups on the substrate. 
 
Transducers 
Electrochemical Transducers  
Electrochemical transducers use enzymes to generate an electrochemical signal, either 
amperometric or potentiometric (amperometric being more sensitive).  For example, 
Field Effect Transistors (FETs) have their conductance modulated by the gate voltage 
through the field effect of a semiconductor.  Ion-sensitive FETs (ISFETs) are most often 
used and allow for the detection of acidic or alkaline species during enzyme reactions. 
 
Piezoelectric Transducers  
Piezoelectric transducers use piezoelectric crystals that change dimensions when 
subjected to current or voltage.  These are coated with a receptor that will alter the 
frequency of crystal vibration when a biological agent attaches to the receptor material 
coating.  This is an example of an acoustic sensor that indicates changes in mass or 
viscosity on the surface layer.  Acoustic sensors also make use of the piezoelectric 
properties of a substrate to indicate changes in mass or viscosity of the surface layer.   
   
Optical Transducers  
Optical transducers can use light scattering or absorbance, but usually use fluorescent or 
other luminescence spectroscopy.  For example, fiber-optic biosensors result from the 
interaction of a reagent phase that incorporates an immobilized biological agent with a 
transducing system comprising an optical fiber connected to a light detector.   
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Thermal Sensors  
Thermal sensors can be used as thermistors to detect exothermic heat generated from an 
enzyme reaction. 
 
Sandia National Laboratories is currently developing a biosensor based on current 
immunoassay technology coupled with acoustic transducers.  The receptor is composed 
of OH-terminated alkanethiol layer bound to the substrate.  Then phospholipid vesicles 
are added to form a phospholipid bilayer, on which streptavidin and then biotinylated 
antibodies can be bound.  This receptor layer is self-assembling and can be easily 
removed by washing the lipid bilayer in a detergent, allowing the operator to use the 
same sensor more than once.  This particular Sandia-patented device17, the novel 
magnetically-driven flexural-plate wave device (mag-FPW), is used as the acoustic 
transduction element upon which the receptor membrane is bound.  This particular 
transducer can be tuned to maximize its mass and viscoelastic sensitivity, is used in both 
liquid- and vapor-phase detection, and be easily miniaturized and integrated into an array.   
 
 
Biomaterials 
 
Complicated nanosystems can be designed through use of biomimetic principles.  Living 
systems and their molecular structures are observed by researchers and can be 
modeled by using applied biological sciences.  Biomimetics entails researching 
structure and organization of biomolecules, cells, tissues and biological systems, and 
then designing based upon these observations.  For example, a ribosome is a powerful 
manufacturing tool used by the body to synthesize products valuable to physiological 
health.  Its structure, function, and information flow may be studied and used for 
inspiration of a nano-device made of synthetic materials that will not coagulate in, or be 
affected by, environmental extremes.18  The possibilities of biologically-inspired designs 
are endless when coupled with other science and technologies, especially 
nanotechnology.   
 
Biomimetic materials use the biological world for the inspiration of new materials for use 
in a wide range of fields including: 
• Aerospace Engineering 
• Bioengineering 
• Computer Science Engineering 
• Electrical Engineering 
• Materials Science Engineering 
• Mechanical Engineering 
 
Biomimetic materials have been used in the design of aircraft and swimwear intended to 
mimic the unique qualities of sharkskin in order to reduce form drag in the water and air 
by up to 8%.19  This design has also been used in trains whose outer coverings have ribs 
parallel to the flow of air in order to reduce drag.   
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Composites currently are being designed to mimic some of the biocomposites found 
inside the human body.  Bone, connective tissue, and mucus are very good examples.  
Non-human biologics have also contributed to many applications ranging from analysis 
of abalone shells to design composites with similar mechanical properties for 
architectural applications.   
 
Velcro is a commonly-used material whose design was inspired by the observation of 
burred seed shells that cling to hair.  New “smart” adhesives have been designed that 
have molecular hooks that attach to small corresponding springs.  These adhesives are 
comparable to Velcro on a molecular scale.  They are sensitive to heat, loosening grip at 
around 80ºC.20 
 
Smart hydrogels also are biomimetic materials that are important for use in biochemical 
manufacturing.  They consist of hydrogels that are able to respond to changes found in 
their environment.  One way they respond is by changing their level of swelling (swelling 
ratio).  The stimulus that causes change could be a change in pH, temperature, electric 
field, ionic strength, salt type, solvent, stress, light, or pressure.21  Changes in the 
swelling ratio could be used to set up a feedback system for the delivery of a drug or 
other agent.   
 
Biomimetic design is not limited to the mechanical aspects of natural systems.  For 
example, genetic algorithms are based upon random mutation as well as natural selection, 
but are not themselves models of evolution.  This does not suggest that biological 
systems are optimized systems.  However, they have the potential to help inspire good 
engineering designs.22 
 
There is much to learn by observing the way that biological systems make what they need 
or change the properties of what they already have.  The most visual representation of 
biomimetic design is structure.  In biological systems, structure is very closely related to 
function.  By knowing more about this relationship, we may be able to mimic some of the 
more useful structures that are already available in nature.  It is also important to 
understand what properties of a system or material we are trying to mimic.23    
 
Nature produces some very complicated biomolecular structures that science does not 
fully understand, i.e. proteins.  To mimic biomolecules, additional research into 
protein/biomolecule structure-function and synthesis techniques will need to take place.   
Science continues to build on the phenomena exhibited by nature.  Manufacturers can 
learn from the complex interactions that have brought nature to its current level of 
efficiency. 
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Biocomputation 
 
Biocomputation is a combination of computer science and biology that attempts to 
build computational models of real biological systems.  Experts use the tools and 
concepts of information science.  One goal is to see biological systems from a different 
paradigm.  Another is to use biological systems or processes as a metaphor, or 
inspiration.  It may also act to enable and catalyze the development of new computing 
technologies as well as new areas of computer science.   
 
Biocomputing should not be confused with bioinformatics (data handling) or 
computational biology (simulations).  Rather biocomputing focuses on the intersection 
between computer science and biology.  Biocomputation is involved with: 
• Computational properties of cells 
• DNA Computation 
• DNA Self Assembly 
• Cellular and DNA Logic Gates 
• Computer Immune Systems 
• Artificial Intelligence (AI) 
• Artificial Neural Nets 
• Genetic and Evolutionary Algorithms 
 
Cells can serve as models for sensors or digital logic gates.  Currently, cellular logic gates 
are being produced that use cellular inverters made up of proteins that either suppress or 
activate the production of other proteins as an on/off switch.  Additionally, genetic 
regulatory networks can be simulated using computer science concepts and knowledge of 
how cells process information, yielding benefits to molecular biology.  In general, 
applying computer science techniques to cellular events is helping biologists to 
understand these events.   
 
Protein-based electronic devices were first developed in the former Soviet Union around 
1975.  The goal was to create a three-dimensional (3D) memory system that would far 
exceed the capacity of western memory systems.  One major Soviet development was the 
creation of biochrome, a real-time photochromic and holographic film based on 
chemically-modified polymer films containing Bacteriorhodopsin (BR).  A review of this 
research can be found in the papers of Vsevolodov and Poltoratskii.24  
 
Bacteriorhodopsin (BR) is a protein that has unique photophysical properties.  It is known 
to be highly stable under thermal and photo-physical extremes.  The protein has good 
light-to-energy conversion properties and is thus well-suited for a number of computer 
and data storage applications.  BR is isolated from the salt marsh archaebacteria called 
Halobacterium salinarium.  This protein is known for its ability to maintain its structure 
and function at temperatures as high as 140°C, a temperature that would cause most 
proteins to lose function and/or coagulate.25 
 
To be more specific, BR is a photon-driven ion pump that consists of a seven-helical 
transmembrane protein with a retinal co-factor.  In the parent bacterium H. salinarium, 
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BR converts light to a proton gradient, which is then used by a second membrane protein 
called ATP synthase to generate chemical energy in the form of ATP (adenosine 5’-
triphosphate).  The cell then uses ATP to drive a multitude of vital processes.26   
 
There is a protein in the human eye called Rhodopsin that enables us to detect light.  
Although this protein has similar structural properties to BR, it is very different in 
function.  Rhodopsin would not be a good choice for computing because it is destroyed 
during usage.  Bacteriorhodopsin can be used many times, however, before it denatures.   
 
The protein BR cycles through a series of spectrally distinct intermediates upon 
absorption of light.  Chromophores, a light-absorbing group embedded in the protein 
matrix, convert light energy into a complex series of molecular events that store energy.  
This complex series of reactions causes changes in the optical and electronic properties of 
the protein.  BR has good holographic properties because of the large (65%), highly-
efficient change in refractive index.  This protein is known to be 10 times smaller than 
the wavelength of light.  Therefore, the resolution of the thin film is determined by the 
diffraction limit of the optical geometry rather than by the graininess of the film.  BR 
absorbs two photons at a time and consequently it can be used to store information in 
three dimensions by using two-photon architectures.  Because BR was naturally 
engineered to function in conditions of high temperature and light intensity, it can be 
used to create very robust devices.   
 
BR, like any protein, can be engineered to enhance its natural properties or at least tailor 
them to a specific task.  Therefore, the BR protein can be used as a template to design 
novel proteins through genetic engineering principles for use in biomolecular-electronic 
devices.  In essence, this protein is the prototype for future protein-based devices.   
 
Because of its unique properties, BR has been used in the design and development of 
holographic and volumetric 3D memories.  Holographic memories are based upon the 
protein’s ability to form an M-state and thus produce a large change in refractive index.  
In fact, films of BR can generate diffraction efficiencies of about 8%.27  This property 
makes the protein capable of performing holographic data storage.  With the 
manipulation of the protein through mutation, it has become competitive with 
photorefractive polymers.  Thin and thick films of BR can be prepared in variable 
concentrations for optimal optical architecture.   
 
Holographic memories can be made to operate effectively in three dimensions using 
proteins.  Data can be stored in such a holographical system using a sequential pair of 
one-photon processes, making possible the use of diode lasers to source one bit into the 
long-lived Q state.28  Such a memory system can store 3 times the amount of information 
normally stored in the same amount of space.  Such memories are extremely robust and 
can withstand fierce gravitational forces, electromagnetic radiation, and cosmic rays.  
These memories are also low cost, lightweight, and resistant to moisture.  These devices 
can be submerged in water for extended periods of time without loss of data.   
 
  37
Because BR is a protein, its development is bottlenecked by the same factors affecting 
advancements in protein engineering.  Limitations include the lack of satisfactory 
molecular modeling tools and understanding of the structure-to-function relationships 
presented by the natural complexity.  It may not be realistic to expect a design team to 
use protein-engineering tools to enhance the holographic properties of this protein 
without some unforeseen difficulties.  At this time, protein engineering is still done by 
trial and error.   
 
Researchers have also been able to use BR in the construction of neural computer 
memory design as the photoactive holographic media in thin films.29  The idea is to create 
associative memories like the memory believed to function in the human brain.  
Associative memories operate by scanning the entire memory for the data block that 
matches the input.  It may also be capable of locating the closest match. 
 
Artificial neural nets are computer algorithms that mimic the way neurons in the brain 
process information.  They are used in an iterative methodology where real data are used 
to train the artificial neural net to recognize certain patterns.  Genetic and evolutionary 
algorithms are computer programs based upon the concept of simulating evolution 
through natural selection, mutation, and reproduction.  Artificial intelligence studies 
natural life by attempting to recreate biological phenomena using computers and other 
artificial media.   
 
Bioinformatics 
Bioinformatics is one of the most important contributors to biomanufacturing.  It involves 
the handling of all of the data produced by any of the bio-related fields.  It can also 
include the application of statistical techniques to the management of information, 
creation and management of databases, and analysis of DNA sequence data.  In general, 
bioinformatics describes any use of computers to handle biological information.  To most 
people, bioinformatics is a synonym for computational molecular biology, the use of 
computers to characterize the molecular components of living things.30  There are a 
number of subcategories within the field of bioinformatics including:  
• Comparative genomics, a search for similarities and differences in all the genes of 
multiple species, 
• Cheminformatics, the analysis and database maintenance of information from the 
study of molecular-level chemistry, and  
• Medical informatics, the management of all biomedical experimental data.  
 
Bioinformatics tools can be used to obtain sequences of genes or proteins of interest, 
either from material obtained directly from researchers or from repositories of previously 
prepared and investigated sequences.  Analysis of sequence data can be accomplished in 
a number of ways. 
 
One of the most difficult tasks that falls under the field of bioinformatics is the assembly 
of gene sequence data.  Genetic sequencing can only be done on small pieces of the 
genome at a time, so the product of all of the sequencing data is a huge array of 
overlapping sequences.  Bioinformatics can be used to assemble those pieces into one 
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continuous code using gene mapping.  Gene mapping determines where the restriction 
enzymes have cut the genome, and where they can be pasted back together.  Genes that 
look remarkably similar to one another, called homologues, are likely to be related to one 
another.  This relationship between proteins is used to trace evolutionary family trees, 
and can be used to track the changes in biomolecules through time.  The sheer volume of 
data makes sequence assembly extremely laborious, requiring extensive and expensive 
computing power.   
 
Once a homologue has been uncovered, then the newly discovered protein may be 
modeled.  Molecular modeling and structural biology are growing fields that are 
considered part of bioinformatics.  The model, a three-dimensional structure of the gene 
product, can be predicted without the need for laboratory experiments.  In this way, 
bioinformatics is used to predict the function of gene products.  There are, for example, 
tools that allow a user (often via the Net) to make reasonably good predictions of the 
secondary structure of proteins arising from a given amino acid sequence.  These 
predictions are based on known "solved" structures and other sequenced molecules 
acquired by structural biologists.  Structural biologists use bioinformatics to handle the 
vast and complex data from X-ray crystallography, nuclear magnetic resonance (NMR), 
and electron microscopy investigations, and to create the 3D models of molecules that are 
commonly seen in journal articles.   
 
There are other disciplines of biologically-inspired computation that include genetic 
algorithms, artificial intelligence, and neural networks.  Often these areas interact in 
strange ways.  Neural networks, inspired by crude models of the functioning of nerve 
cells in the brain, are used in a program called PHD to predict, somewhat accurately, the 
secondary structures of proteins from their primary sequences.  What almost all 
bioinformatics has in common is the processing of large amounts of biologically-derived 
information, whether it consists of DNA sequences or breast X-rays.31 
 
 
Bioenergy 
 
Fossil fuels represent 80% of the energy that we consume at this time.  Biobased 
products and bioenergy from crops, trees, and agriculture, as well as industrial, 
municipal, and forestry waste, hold great promise for the future.  We can use the 
energy and molecular binding blocks of plants to produce fuels, provide chemical 
feedstocks, and generate electrical power.  Each year around 100 billion tons of 
biomass are created worldwide, which contain an energy value equal to five times the 
current total global energy consumption.  Most biomass is currently burned or left to 
biodegrade, and little is turned into useful energy or other products.  This is because it is 
widely dispersed and difficult to capture.  In the U. S. biomass supplies only 3% of the 
nation’s total energy consumption.  In the future, experts anticipate that biomass will play 
a far greater role.32   
 
The following useful terms are defined in section 303(2) of the Biomass Research and 
Development Act of 2000:33 
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• Biomass – Any organic matter that is available on a renewable or recurring basis, 
including agricultural crops and trees, wood and wood wastes and residues, plants 
(including aquatic plants), grasses, residues, fibers, and animal wastes, municipal 
wastes, and other waste materials.  
 
• Biobased industrial products – Fuels, chemicals, building materials, or electric 
power or heat produced from biomass. 
 
• Biofuels – Liquid fuels produced from biomass that are used in stationary and 
mobile applications. 
 
• Biopower – Includes new installations using 100 percent biomass or a blend of 
biomass and fossil fuel; the installation of co-firing systems at existing fossil fuel-
based generating station; and repowering options involving biomass. 
 
There are substantial benefits to fully utilizing these potential bioenergy sources 
including: 
• Enhanced national energy security 
• Improved environmental protection 
• Rural economic growth 
• Sustainable global development 
 
The fast development of the bioengineering of plants as well as the “synergistic 
production” of agricultural and chemical feedstocks, and the conversion of wastes and 
other biomass into energy is underway.  Plant-based materials may soon be designed to 
yield novel polymers or to maximize inherent energy.  Technologies may also tap the 
possibilities of using aquatic biomass.  In time, engineered processes might mimic plant 
photosynthetic processes and act to directly convert the sun’s rays into high-energy 
materials.32 
 
One option for future energy production that reduces the use of petroleum products is the 
use of coal.  Coal is in abundance and can be liquefied or gasified to replace petroleum-
based products.  There are, however, environmental problems associated with the use of 
coal, such as emission of nitrogen oxides, sulfur dioxides, particulates, and carbon 
dioxide.32 
 
Biomass can be used to generate electricity, provide liquid fuels and chemical feedstocks, 
and extract hydrogen from water.  However, there are numerous potential technical 
issues.  For example, the cultivation of biomass energy sources must be balanced with 
other demands on the land and water.  In addition, the long-term safety of genetically 
engineering plants must be assessed.     
 
Usually the term “biomass” refers to lignin and cellulosics.  Development in the 
advanced gasification of such resources may result in more efficient energy retrieval.  
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Also, enzymatic conversion of lignocellulosic biomass is revolutionizing the way we use 
agricultural crops, as well as fast growing trees and other plant parts, to produce ethanol.   
 
Dramatic scientific developments in such areas as genomics of transgenic plants are 
creating new possibilities for development of new biomass resources.  These new types 
of plants and microorganisms could potentially yield novel polymers, high-energy-
content hydrocarbons, and other important products.  However, genetic biotechnologies 
remain controversial.  They have resulted in impressive gains in productivity and yields 
in agriculture, but the long-term ecological and health effects of genetic biotechnologies 
are the subjects of much debate.   
 
One major developing area of research involves alteration of plant metabolic pathways to 
produce carbon molecules with useful functional properties.  To do this scientists and 
engineers will need to obtain a better understanding of not just the actual plant 
metabolism but also the regulation of carbon flow.  There is also a need to address the 
concern that this technology will have a negative impact upon the ecosystem.  As gene 
technology is improved, there will be better control of plants at the genetic level.  This 
will enable use of this technology for practical, every-day usage.   
 
Plant productivity also needs to be improved.  Chemical consistency studies will need to 
take place.  Also, an improved understanding of the factors and theory of sustainable 
agriculture will provide a stronger foundation for this method of biobased product and 
bioenergy production.   
 
Bio-refineries have the potential to produce energy and biobased products.  Agricultural, 
forestry, and methane products would be used as the raw material in such refineries.  It is 
also possible to exploit landfill, animal, and plant wastes as potential bioenergy sources.  
Another possibility lies in the conversion of light into energy using natural photosynthetic 
processes coupled with special enzymes.  This combination could be used to design a 
solar panel to capture solar energy for use in carbon fixing reactions aimed at the 
production of energy-rich products.   
 
Processing and conversion involves the separation and conversion of biomass materials 
into power, fuels, and products.32  R&D is needed to develop the following technologies: 
• More economical separation techniques 
• Enzymatic and thermal processing 
• Biomass material conversion processes 
• Improved fermentation processes 
• Improved reduction chemistry 
• Capital cost reduction strategies 
• Biopower systems 
• Advanced processing strategies in biorefineries 
 
In addition, The DOE Advisory Committee made the following recommendations for 
research and development of biofuels: 32 
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• Advanced methods to overcome the resistance of agricultural, forest-based, and 
urban feedstocks to enzymatic and fermentation treatments.  
• An understanding of the fundamental structure of lignocellulosic materials, 
including the chemistry of its cell wall structures, transport properties, and genetic 
properties, to improve growth rates and processing characteristics.  Agronomic, 
economic, and environmental impacts of harvesting lignocellulosic material must 
be established to ensure that the use of these materials results in beneficial 
lifecycle impacts.   
• Pretreatment technologies that make utilization of both current and new 
feedstocks more effective and less expensive.   
• Traditional thermo-chemical and catalytic processing to convert starches, sugars, 
and cellulosic material into fuel.  This fits into broader biorefinery concepts.   
• Sensors for quick, cost-effective systems for on-line, real-time analysis and 
maintenance of feedstocks.   
• Biorefineries that use complex strategies to efficiently produce a diverse and 
flexible mix of conventional products, fuels, electricity, heat, chemicals, and 
material products from all available, environmentally appropriate biomass 
feedstocks.  Current biorefineries need improved processing efficiency. 
• Research in utilization that examines the fundamental properties of biofuels in 
pure form and in combination with petroleum-based fuels.   
• Research in systems management that examines the systems that compose the 
biofuels industry that include feedstock production and harvesting, feedstock 
transportation, fuel production, transportation of finished products, and 
distribution to end-users.   
 
In order to use these biofuels, additional research and development is required in the 
fields of thermochemical conversion, co-firing, direct combustion, thermal gasification, 
anaerobic fermentation gas production, modular systems, and feedstocks.34  Investigation 
into these areas could enable the U. S. to use bioenergy sources to supply the majority of 
its energy requirements.   
 
 
Conclusions and Recommendations 
 
Biomanufacturing is an advanced manufacturing technology that involves the use of 
chemical, physical, and biological processes performed by living cells for use in other 
applications.  Biomanufacturing enables the manufacture of products with unique 
characteristics and has significant potential in the manufacture of several products such as 
polymers, energy sources, chemicals, food products, pharmaceuticals, and biodegradation 
(remediation) of hazardous materials.  Biomanufacturing encompasses technologies such 
as: 
• Biotechnology 
• Bioengineering 
• Biodetection 
• Biomaterials 
• Biocomputation 
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• Bioenergy 
 
Perhaps the most unique and advantageous aspect of biomanufacturing is the excellent 
control that may be afforded during fabrication.  In particular, sequence-by-sequence 
building of polymeric materials may be possible.  Biological species can be used to 
synthesize polymers of more uniform chain lengths or chain branching than those 
produced by conventional synthesis techniques.  For example, biomolecules could be 
used in place of metallocene catalysts in the production of commodity polymers (e.g. 
polyethylene and polypropylene), resulting in improved performance at a reduced cost 
and energy consumption.  Additionally, biosynthesis could be used to produce specialty 
copolymers that are not available through traditional synthesis methods.  These 
applications are of particular interest to SNL as we strive to understand polymers and 
nanoparticles in terms of their thermal, mechanical, optical, and electrical properties for 
use in nuclear weapons, satellites, and homeland defense applications. 
 
Biomineralization, a bioprocess that involves the controlled agglomeration of atoms or 
molecules, is also of interest as it enables the fabrication of unique fillers and 
nanoparticles.  This process can produce organized structures more efficiently than 
current technology that uses self-assembled structures.  The organized structures can be 
used in templating that can be used to produce clear, high-strength composites and high-
refractive-index materials for solid-state-lighting applications.   
 
Other biomanufacturing areas of interest include sensors, encryption tools, and adhesives.  
It may be possible to utilize this technology to manufacture sensors that offer superior 
recognition of chemical and biological agents.  Currently, it is possible to manufacture 
sensors that are able to detect only one or a few agents.  However, development of the 
appropriate bioprocessing techniques will enable manufacture of sensors that are able to 
detect all materials of interest at once.  This is of tremendous interest in detecting and 
neutralizing potential terrorist attacks using these agents.  Additionally, it may be 
possible to use biosequencing to provide encryption and subsequent decoding of 
complex, sensitive data.   
 
Biomanufacturing has the potential to be one of the defining technologies in the 
upcoming century.  Research, development, and applications in the fields of 
biotechnology, bioengineering, biodetection, biomaterials, biocomputation and bioenergy 
will have dramatic impact on both the products we are able to create, and the ways in 
which we create them.  Sandia National Laboratories has the expertise to contribute to 
any one of these fields.   
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